GSE155528 ING1 ING2 inhibition 2 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE155528_ING1_ING2 inhibition_2_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE155528_ING1_ING2 inhibition_2_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE155528_ING1_ING2 inhibition_2_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE155528_ING1_ING2 inhibition_2_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

zinc finger protein 204, pseudogene

Gene

long intergenic non-protein coding RNA 632

Gene

WT1 antisense RNA

Gene

HOXB cluster antisense RNA 3

Gene

AZGP1 pseudogene 1

Gene

BCL2 interacting protein 3 pseudogene 17

Gene

DPP10 antisense RNA 1

Gene

long intergenic non-protein coding RNA 1619

Gene

uncharacterized LOC105372126

Gene

uncharacterized LOC442497

  • Gene

    zinc finger protein 204, pseudogene


  • Gene

    long intergenic non-protein coding RNA 632


  • Gene

    WT1 antisense RNA


  • Gene

    HOXB cluster antisense RNA 3


  • Gene

    AZGP1 pseudogene 1


  • Gene

    BCL2 interacting protein 3 pseudogene 17


  • Gene

    DPP10 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 1619


  • Gene

    uncharacterized LOC105372126


  • Gene

    uncharacterized LOC442497

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.